頁面路徑選單
Orthopedic Software Market by Product Applications Mode of Delivery - Global Forecast to 2020
出 版 商：MarketsandMarkets
出版日期：2015/03/23
頁 數：141頁
文件格式：PDF
價 格：
USD 4,650 (Single-User License)
USD 5,650 (Multi-User License)
USD 9,000 (Global-User License)
USD 5,650 (Multi-User License)
USD 9,000 (Global-User License)
Orthopedic software is used before, during and after orthopedic surgeries by surgeons. While there are different types of software used by orthopedic surgeons, digital templating software is most widely used, as they enable advanced orthopedic surgical planning. Orthopedic EHR and orthopedic picture archiving and communication systems (PACS) are also some of the other software preferred by orthopedic surgeons.
The global orthopedic software market is expected to grow at a CAGR of 5.1% from 2014 to 2020. The global orthopedic software market is largely driven by rising incidences of orthopedic ailments such as arthritis and osteoporosis, high number of orthopedic surgeries, and growing geriatric population which is more prone to orthopedic related problems. Focus on minimally invasive techniques for knee and hip surgeries as compared to traditional orthopedic surgeries is also expected to propel the growth of this market.
The global orthopedic software market is broadly segmented by products, applications, and mode of delivery. The products market is further sub-segmented into pre-operative planning software, orthopedic EHR, practice management, orthopedic picture archiving and communication systems (PACS), and orthopedics revenue cycle management (RCM). The market by applications includes orthopedic surgeries, joint replacement, fracture and limb deformity management, and pediatric assessment. Based on the mode of delivery the market is further sub-divided into web-based, cloud based, and on premises systems.
While the North American and European markets for orthopedic software remain highly penetrated, Asia-Pacific is expected to register the highest growth during the forecast period. This is majorly attributed to increasing investment in healthcare IT and rising awareness especially in countries such as China and Japan from this region. Materialise NV (Belgium), Merge Healthcare Inc. (U.S.), Brainlab AG (Germany), CureMD (U.S.), Medstrat, Inc. (U.S.), HealthFusion Inc. (U.S.), McKesson Corporation (U.S.), and Greenway Health (U.S.) are some of the prominent players in this market. Acquisitions and new product launches are some of the major strategies adopted by these players to maintain their market share and growth in this market.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the orthopedic software market. The report analyzes the orthopedic software market by type of products, applications, and mode of delivery.
Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the orthopedic software market.
Market Development: Comprehensive information about the lucrative emerging markets by product, applications, and geography.
Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the orthopedic software market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the orthopedic software market.
The global orthopedic software market is expected to grow at a CAGR of 5.1% from 2014 to 2020. The global orthopedic software market is largely driven by rising incidences of orthopedic ailments such as arthritis and osteoporosis, high number of orthopedic surgeries, and growing geriatric population which is more prone to orthopedic related problems. Focus on minimally invasive techniques for knee and hip surgeries as compared to traditional orthopedic surgeries is also expected to propel the growth of this market.
The global orthopedic software market is broadly segmented by products, applications, and mode of delivery. The products market is further sub-segmented into pre-operative planning software, orthopedic EHR, practice management, orthopedic picture archiving and communication systems (PACS), and orthopedics revenue cycle management (RCM). The market by applications includes orthopedic surgeries, joint replacement, fracture and limb deformity management, and pediatric assessment. Based on the mode of delivery the market is further sub-divided into web-based, cloud based, and on premises systems.
While the North American and European markets for orthopedic software remain highly penetrated, Asia-Pacific is expected to register the highest growth during the forecast period. This is majorly attributed to increasing investment in healthcare IT and rising awareness especially in countries such as China and Japan from this region. Materialise NV (Belgium), Merge Healthcare Inc. (U.S.), Brainlab AG (Germany), CureMD (U.S.), Medstrat, Inc. (U.S.), HealthFusion Inc. (U.S.), McKesson Corporation (U.S.), and Greenway Health (U.S.) are some of the prominent players in this market. Acquisitions and new product launches are some of the major strategies adopted by these players to maintain their market share and growth in this market.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the orthopedic software market. The report analyzes the orthopedic software market by type of products, applications, and mode of delivery.
Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the orthopedic software market.
Market Development: Comprehensive information about the lucrative emerging markets by product, applications, and geography.
Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the orthopedic software market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the orthopedic software market.
TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 18
1.5 LIMITATIONS FOR THE STUDY 18
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH APPROACH 20
2.2 MARKET SIZE ESTIMATION 22
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 MARKET SHARE ESTIMATION 25
2.5 KEY DATA FROM SECONDARY SOURCES 25
2.6 KEY DATA FROM PRIMARY SOURCES 26
2.6.1 KEY INDUSTRY INSIGHTS 27
2.7 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 32
4.1 MARKET OPPORTUNITIES IN THE ORTHOPEDIC SOFTWARE MARKET 32
4.2 NORTH AMERICAN ORTHOPEDIC SOFTWARE MARKET, BY PRODUCT 33
4.3 ORTHOPEDIC SOFTWARE MARKET: REGIONAL GROWTH OPPORTUNITIES 34
4.4 ORTHOPEDIC SOFTWARE MARKET, BY PRODUCT: GEOGRAPHIC MIX 35
4.5 ORTHOPEDIC SOFTWARE MARKET: DEVELOPED VS. DEVELOPING MARKETS 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.2.1 BY PRODUCT 38
5.2.2 BY APPLICATION 38
5.2.3 BY MODE OF DELIVERY 38
5.3 MARKET DYNAMICS 39
5.3.1 KEY MARKET DRIVERS 40
5.3.1.1 Rising need to curtail healthcare costs 40
5.3.1.2 Rising incidence of orthopedic conditions 40
5.3.1.3 Growth in aging population 41
5.3.2 KEY MARKET RESTRAINS 42
5.3.2.1 Lower adoption and reluctance among orthopedicians to use orthopedic software 42
5.3.3 KEY MARKET OPPORTUNITIES 43
5.3.3.1 Availability of orthopedic software as cloud-based solutions and its use in mobile platforms 43
5.3.4 KEY MARKET CHALLENGES 44
5.3.4.1 Consolidation of technology due to mergers between healthcare set-ups 44
6 INDUSTRY INSIGHTS 45
6.1 INTRODUCTION 45
6.2 INDUSTRY TRENDS 45
6.2.1 INTEGRATION OF ORTHOPEDIC EHR WITH PRACTICE MANAGEMENT SOFTWARE 45
6.2.2 ACQUISITIONS BY MAJOR PLAYERS TO ENHANCE THEIR PRODUCT PORTFOLIOS 46
6.3 PORTER’S FIVE FORCES ANALYSIS 46
6.3.1 THREAT OF NEW ENTRANTS 46
6.3.2 THREAT OF SUBSTITUTES 47
6.3.3 BARGAINING POWER OF SUPPLIERS 47
6.3.4 BARGAINING POWER OF BUYERS 47
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 48
6.4 STRATEGIC BENCHMARKING 48
6.4.1 ACQUISITIONS OF SMALL PLAYERS WERE THE MOST COMMONLY ADOPTED STRATEGY 48
7 ORTHOPEDIC SOFTWARE MARKET, BY PRODUCT 50
7.1 INTRODUCTION 51
7.2 ORTHOPEDIC PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) 51
7.3 ORTHOPEDIC ELECTRONIC HEALTH RECORDS 53
7.4 DIGITAL TEMPLATING/PRE-OPERATIVE PLANNING SOFTWARE 54
7.5 ORTHOPEDIC PRACTICE MANAGEMENT 56
7.6 ORTHOPEDIC REVENUE CYCLE MANAGEMENT (RCM) 57
8 ORTHOPEDIC SOFTWARE MARKET, BY APPLICATION 59
8.1 INTRODUCTION 60
8.2 JOINT REPLACEMENT 61
8.3 FRACTURE MANAGEMENT 63
8.4 PEDIATRIC ASSESSMENT 64
?
9 ORTHOPEDIC SOFTWARE MARKET, BY MODE OF DELIVERY 66
9.1 INTRODUCTION 67
9.2 WEB-BASED SOFTWARE 67
9.3 ON-PREMISES SOFTWARE 69
9.4 CLOUD-BASED SOFTWARE 70
10 ORTHOPEDIC SOFTWARE MARKET, BY REGION 72
10.1 INTRODUCTION 73
10.2 NORTH AMERICA 74
10.2.1 U.S. 77
10.2.2 CANADA 79
10.3 EUROPE 81
10.3.1 GERMANY 84
10.3.2 U.K. 85
10.3.3 FRANCE 87
10.3.4 ITALY 89
10.3.5 SPAIN 90
10.3.6 REST OF EUROPE (ROE) 92
10.4 ASIA-PACIFIC (APAC) 93
10.4.1 JAPAN 97
10.4.2 INDIA 99
10.4.3 CHINA 100
10.4.4 REST OF ASIA-PACIFIC (ROAPAC) 102
10.5 REST OF THE WORLD (ROW) 104
10.5.1 LATIN AMERICA 105
10.5.2 MIDDLE EAST AND AFRICA 107
11 COMPETITIVE LANDSCAPE 109
11.1 OVERVIEW 109
11.2 MARKET SHARE ANALYSIS 110
11.3 COMPETITIVE SITUATION AND TRENDS 112
11.3.1 MERGERS AND ACQUISITIONS 112
11.3.2 AGREEMENTS, PARTNERSHIPS, AND ALLIANCES 114
11.3.3 NEW PRODUCT LAUNCHES 115
11.3.4 OTHER DEVELOPMENTS 115
12 COMPANY PROFILES 117
12.1 BRAINLAB AG 117
12.1.1 BUSINESS OVERVIEW 117
12.1.2 PRODUCT PORTFOLIO 117
12.1.3 KEY STRATEGY 118
12.1.4 RECENT DEVELOPMENTS 118
12.1.5 MNM VIEW 118
12.2 GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY) 119
12.2.1 BUSINESS OVERVIEW 119
12.2.2 GE COMPANY: COMPANY SNAPSHOT 119
12.2.3 PRODUCT PORTFOLIO 120
12.2.4 KEY STRATEGY 120
12.2.5 RECENT DEVELOPMENTS 120
12.2.6 MNM VIEW 120
12.3 MATERIALISE N.V. 121
12.3.1 BUSINESS OVERVIEW 121
12.3.2 PRODUCT PORTFOLIO 121
12.3.3 KEY STRATEGY 121
12.3.4 RECENT DEVELOPMENTS 122
12.3.5 MNM VIEW 122
12.4 MERGE HEALTHCARE INCORPORATED 123
12.4.1 BUSINESS OVERVIEW 123
12.4.2 MERGE HEALTHCARE INCORPORATED: COMPANY SNAPSHOT 123
12.4.3 PRODUCT PORTFOLIO 124
12.4.4 KEY STRATEGY 124
12.4.5 RECENT DEVELOPMENTS 124
12.4.6 MNM VIEW 124
12.5 PHILIPS HEALTHCARE (A DIVISION OF KONINKLIJKE PHILIPS N.V.) 125
12.5.1 BUSINESS OVERVIEW 125
12.5.2 PHILIPS: COMPANY SNAPSHOT 125
12.5.3 PRODUCT PORTFOLIO 125
12.5.4 KEY STRATEGY 126
12.5.5 MNM VIEW 126
12.6 CUREMD HEALTHCARE 127
12.6.1 BUSINESS OVERVIEW 127
12.6.2 PRODUCT PORTFOLIO 127
12.6.3 KEY STRATEGY 127
12.6.4 RECENT DEVELOPMENTS 128
12.7 GREENWAY HEALTH, LLC. 129
12.7.1 BUSINESS OVERVIEW 129
12.7.2 PRODUCT PORTFOLIO 129
12.7.3 KEY STRATEGY 129
12.7.4 RECENT DEVELOPMENTS 130
12.8 HEALTHFUSION, INC. 131
12.8.1 BUSINESS OVERVIEW 131
12.8.2 PRODUCT PORTFOLIO 131
12.8.3 KEY STRATEGY 131
12.8.4 RECENT DEVELOPMENTS 131
12.9 MCKESSON CORPORATION 132
12.9.1 BUSINESS OVERVIEW 132
12.9.2 MCKESSON CORPORATION: COMPANY SNAPSHOT 132
12.9.3 PRODUCT PORTFOLIO 133
12.9.4 KEY STRATEGY 133
12.10 MEDSTRAT, INC. 134
12.10.1 BUSINESS OVERVIEW 134
12.10.2 PRODUCT PORTFOLIO 134
12.10.3 KEY STRATEGY 134
12.10.4 RECENT DEVELOPMENTS 134
13 APPENDIX 135
13.1 INSIGHTS OF INDUSTRY EXPERTS 135
13.2 DISCUSSION GUIDE 136
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 139
13.4 AVAILABLE CUSTOMIZATIONS 139
13.5 RELATED REPORTS 140
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 18
1.5 LIMITATIONS FOR THE STUDY 18
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH APPROACH 20
2.2 MARKET SIZE ESTIMATION 22
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 MARKET SHARE ESTIMATION 25
2.5 KEY DATA FROM SECONDARY SOURCES 25
2.6 KEY DATA FROM PRIMARY SOURCES 26
2.6.1 KEY INDUSTRY INSIGHTS 27
2.7 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 32
4.1 MARKET OPPORTUNITIES IN THE ORTHOPEDIC SOFTWARE MARKET 32
4.2 NORTH AMERICAN ORTHOPEDIC SOFTWARE MARKET, BY PRODUCT 33
4.3 ORTHOPEDIC SOFTWARE MARKET: REGIONAL GROWTH OPPORTUNITIES 34
4.4 ORTHOPEDIC SOFTWARE MARKET, BY PRODUCT: GEOGRAPHIC MIX 35
4.5 ORTHOPEDIC SOFTWARE MARKET: DEVELOPED VS. DEVELOPING MARKETS 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.2.1 BY PRODUCT 38
5.2.2 BY APPLICATION 38
5.2.3 BY MODE OF DELIVERY 38
5.3 MARKET DYNAMICS 39
5.3.1 KEY MARKET DRIVERS 40
5.3.1.1 Rising need to curtail healthcare costs 40
5.3.1.2 Rising incidence of orthopedic conditions 40
5.3.1.3 Growth in aging population 41
5.3.2 KEY MARKET RESTRAINS 42
5.3.2.1 Lower adoption and reluctance among orthopedicians to use orthopedic software 42
5.3.3 KEY MARKET OPPORTUNITIES 43
5.3.3.1 Availability of orthopedic software as cloud-based solutions and its use in mobile platforms 43
5.3.4 KEY MARKET CHALLENGES 44
5.3.4.1 Consolidation of technology due to mergers between healthcare set-ups 44
6 INDUSTRY INSIGHTS 45
6.1 INTRODUCTION 45
6.2 INDUSTRY TRENDS 45
6.2.1 INTEGRATION OF ORTHOPEDIC EHR WITH PRACTICE MANAGEMENT SOFTWARE 45
6.2.2 ACQUISITIONS BY MAJOR PLAYERS TO ENHANCE THEIR PRODUCT PORTFOLIOS 46
6.3 PORTER’S FIVE FORCES ANALYSIS 46
6.3.1 THREAT OF NEW ENTRANTS 46
6.3.2 THREAT OF SUBSTITUTES 47
6.3.3 BARGAINING POWER OF SUPPLIERS 47
6.3.4 BARGAINING POWER OF BUYERS 47
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 48
6.4 STRATEGIC BENCHMARKING 48
6.4.1 ACQUISITIONS OF SMALL PLAYERS WERE THE MOST COMMONLY ADOPTED STRATEGY 48
7 ORTHOPEDIC SOFTWARE MARKET, BY PRODUCT 50
7.1 INTRODUCTION 51
7.2 ORTHOPEDIC PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) 51
7.3 ORTHOPEDIC ELECTRONIC HEALTH RECORDS 53
7.4 DIGITAL TEMPLATING/PRE-OPERATIVE PLANNING SOFTWARE 54
7.5 ORTHOPEDIC PRACTICE MANAGEMENT 56
7.6 ORTHOPEDIC REVENUE CYCLE MANAGEMENT (RCM) 57
8 ORTHOPEDIC SOFTWARE MARKET, BY APPLICATION 59
8.1 INTRODUCTION 60
8.2 JOINT REPLACEMENT 61
8.3 FRACTURE MANAGEMENT 63
8.4 PEDIATRIC ASSESSMENT 64
?
9 ORTHOPEDIC SOFTWARE MARKET, BY MODE OF DELIVERY 66
9.1 INTRODUCTION 67
9.2 WEB-BASED SOFTWARE 67
9.3 ON-PREMISES SOFTWARE 69
9.4 CLOUD-BASED SOFTWARE 70
10 ORTHOPEDIC SOFTWARE MARKET, BY REGION 72
10.1 INTRODUCTION 73
10.2 NORTH AMERICA 74
10.2.1 U.S. 77
10.2.2 CANADA 79
10.3 EUROPE 81
10.3.1 GERMANY 84
10.3.2 U.K. 85
10.3.3 FRANCE 87
10.3.4 ITALY 89
10.3.5 SPAIN 90
10.3.6 REST OF EUROPE (ROE) 92
10.4 ASIA-PACIFIC (APAC) 93
10.4.1 JAPAN 97
10.4.2 INDIA 99
10.4.3 CHINA 100
10.4.4 REST OF ASIA-PACIFIC (ROAPAC) 102
10.5 REST OF THE WORLD (ROW) 104
10.5.1 LATIN AMERICA 105
10.5.2 MIDDLE EAST AND AFRICA 107
11 COMPETITIVE LANDSCAPE 109
11.1 OVERVIEW 109
11.2 MARKET SHARE ANALYSIS 110
11.3 COMPETITIVE SITUATION AND TRENDS 112
11.3.1 MERGERS AND ACQUISITIONS 112
11.3.2 AGREEMENTS, PARTNERSHIPS, AND ALLIANCES 114
11.3.3 NEW PRODUCT LAUNCHES 115
11.3.4 OTHER DEVELOPMENTS 115
12 COMPANY PROFILES 117
12.1 BRAINLAB AG 117
12.1.1 BUSINESS OVERVIEW 117
12.1.2 PRODUCT PORTFOLIO 117
12.1.3 KEY STRATEGY 118
12.1.4 RECENT DEVELOPMENTS 118
12.1.5 MNM VIEW 118
12.2 GE HEALTHCARE (A DIVISION OF GENERAL ELECTRIC COMPANY) 119
12.2.1 BUSINESS OVERVIEW 119
12.2.2 GE COMPANY: COMPANY SNAPSHOT 119
12.2.3 PRODUCT PORTFOLIO 120
12.2.4 KEY STRATEGY 120
12.2.5 RECENT DEVELOPMENTS 120
12.2.6 MNM VIEW 120
12.3 MATERIALISE N.V. 121
12.3.1 BUSINESS OVERVIEW 121
12.3.2 PRODUCT PORTFOLIO 121
12.3.3 KEY STRATEGY 121
12.3.4 RECENT DEVELOPMENTS 122
12.3.5 MNM VIEW 122
12.4 MERGE HEALTHCARE INCORPORATED 123
12.4.1 BUSINESS OVERVIEW 123
12.4.2 MERGE HEALTHCARE INCORPORATED: COMPANY SNAPSHOT 123
12.4.3 PRODUCT PORTFOLIO 124
12.4.4 KEY STRATEGY 124
12.4.5 RECENT DEVELOPMENTS 124
12.4.6 MNM VIEW 124
12.5 PHILIPS HEALTHCARE (A DIVISION OF KONINKLIJKE PHILIPS N.V.) 125
12.5.1 BUSINESS OVERVIEW 125
12.5.2 PHILIPS: COMPANY SNAPSHOT 125
12.5.3 PRODUCT PORTFOLIO 125
12.5.4 KEY STRATEGY 126
12.5.5 MNM VIEW 126
12.6 CUREMD HEALTHCARE 127
12.6.1 BUSINESS OVERVIEW 127
12.6.2 PRODUCT PORTFOLIO 127
12.6.3 KEY STRATEGY 127
12.6.4 RECENT DEVELOPMENTS 128
12.7 GREENWAY HEALTH, LLC. 129
12.7.1 BUSINESS OVERVIEW 129
12.7.2 PRODUCT PORTFOLIO 129
12.7.3 KEY STRATEGY 129
12.7.4 RECENT DEVELOPMENTS 130
12.8 HEALTHFUSION, INC. 131
12.8.1 BUSINESS OVERVIEW 131
12.8.2 PRODUCT PORTFOLIO 131
12.8.3 KEY STRATEGY 131
12.8.4 RECENT DEVELOPMENTS 131
12.9 MCKESSON CORPORATION 132
12.9.1 BUSINESS OVERVIEW 132
12.9.2 MCKESSON CORPORATION: COMPANY SNAPSHOT 132
12.9.3 PRODUCT PORTFOLIO 133
12.9.4 KEY STRATEGY 133
12.10 MEDSTRAT, INC. 134
12.10.1 BUSINESS OVERVIEW 134
12.10.2 PRODUCT PORTFOLIO 134
12.10.3 KEY STRATEGY 134
12.10.4 RECENT DEVELOPMENTS 134
13 APPENDIX 135
13.1 INSIGHTS OF INDUSTRY EXPERTS 135
13.2 DISCUSSION GUIDE 136
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 139
13.4 AVAILABLE CUSTOMIZATIONS 139
13.5 RELATED REPORTS 140
